Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG) - Concepedia

Concepedia

Publication | Closed Access

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG)

60

Citations

1

References

2001

Year

Cornelis J. A. Punt, P. Fumoleau, Baudouin van de Walle, M.N. Faber, M. Ravic, Mario Campone

Annals of Oncology

OncologySolid TumorsPharmacologyPharmacokinetic StudyNovel SulfonamidePharmacotherapyAnti-cancer AgentCancer TreatmentMedicineCancer Research

References

	Year	Citations

Page 1